Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Adipsin Level

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT06495151Completed

Endometriosis and Complement System

Showing all 1 trials

Research Network

Common Treatments

  • Adipsin Level1
  • Cancer Antigen 125 Ca125 Level1
  • Complement Factor H Cfh Level1
  • Mannosebinding Lectinassociated Serine Protease3 Masp3 Level1
  • Properdin Level1

Active Sponsors

  • Ankara City Hospital Bilkent1

Top Investigators

Related Conditions

  • Complement System1
  • Endometriosis1

Activity Timeline